"Effective June 20, 2021, Carle acquired the assets of Central Illinois Neuro Health Sciences. Carle BroMenn Medical Center (CBMC) and the providers of CINHS (Dr. Ann Stroink, Dr. Emilio Nardone, and Dr. Jason Seibly) share a commitment to bring the best quality care to families in west central Illinois. In addition to a shared emphasis on cultivating the next generation of neuroscience providers, CINHS brings a combined 95 years of specialized neurological care experience in the region. For more information please visit the Carle Neuroscience Institute webpage."

During the past decade, Central Illinois Neuroscience conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Central Illinois Neuroscience" are "Cervical Degenerative Disc Disease" (1 trials) and "Degenerative Cervical Disc Disease" (1 trials). Many other conditions were trialed in "Central Illinois Neuroscience" in a lesser frequency.

Most popular intervention types in "Central Illinois Neuroscience" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "ATLANTIS Anterior Cervical Plate" (1 trials), "Allograft Fusion and ATLANTIS™ Cervical Plate System" (1 trials), "PRESTIGE® Cervical Disc" (1 trials) and "PRESTIGE® LP Cervical Disc" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Illinois Neuroscience" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Central Illinois Neuroscience". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Central Illinois Neuroscience, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central Illinois Neuroscience, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".